$ONC
BeiGene, Ltd. Stock $onc

$onc Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000165130821000086 Filed on May 06, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$605.9M	$52.06M
YoY Change	1063.82%	-33.11%
Cost Of Revenue	$32.69M	$14.15M
YoY Change	131.01%	-7.29%
Gross Profit	$573.2M	$37.91M
YoY Change	1411.97%	-39.41%
Gross Profit Margin	94.61%	72.82%
Selling, General & Admin	$182.1M	$107.1M
YoY Change	70.06%	85.76%
% of Gross Profit	31.77%	282.46%
Research & Development	$320.7M	$304.3M
YoY Change	5.4%	70.62%
% of Gross Profit	55.95%	802.7%
Depreciation & Amortization	$9.632M	$7.750M
YoY Change	24.28%	126.87%
% of Gross Profit	1.68%	20.44%
Operating Expenses	$502.8M	$411.4M
YoY Change	22.23%	74.32%
Operating Profit	$70.17M	-$373.8M
YoY Change	-118.77%	115.11%
Interest Expense	-$68.00M
YoY Change
% of Operating Profit	-96.91%
Other Income/Expense, Net	-$4.123M	$3.681M
YoY Change	-212.01%	113.02%
Pretax Income	$61.87M	-$363.4M
YoY Change	-117.02%	116.88%
Income Tax	-$4.630M	$1.554M
% Of Pretax Income	-7.48%
Net Earnings	$66.50M	-$363.7M
YoY Change	-118.28%	116.97%
Net Earnings / Revenue	10.98%	-698.7%
Basic Earnings Per Share	$0.06	-$0.36
Diluted Earnings Per Share	$0.05	-$0.36
COMMON SHARES
Basic Shares Outstanding	1.189B shares	1.005B shares
Diluted Shares Outstanding	1.257B shares	1.005B shares

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.812B	$3.374B
YoY Change	42.62%
Cash & Equivalents	$1.902B	$1.957B
Short-Term Investments	$2.910B	$1.417B
Other Short-Term Assets
YoY Change
Inventory	$72.97M	$28.78M
Prepaid Expenses
Receivables	$84.01M	$65.62M
Other Receivables	$2.974M	$6.414M
Total Short-Term Assets	$5.141B	$3.595B
YoY Change	43.0%	100.1%
LONG-TERM ASSETS
Property, Plant & Equipment	$373.9M	$240.3M
YoY Change	55.6%	21.5%
Goodwill	$109.0K	$109.0K
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$127.8M	$94.25M
YoY Change	35.62%	60.82%
Total Long-Term Assets	$680.0M	$472.0M
YoY Change	44.07%	25.71%
TOTAL ASSETS
Total Short-Term Assets	$5.141B	$3.595B
Total Long-Term Assets	$680.0M	$472.0M
Total Assets	$5.821B	$4.067B
YoY Change	43.12%	87.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$146.9M	$98.36M
YoY Change	49.37%	-6.6%
Accrued Expenses	$312.1M	$179.3M
YoY Change	74.05%	80.19%
Deferred Revenue	$71.65M
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due	2.654B CNies	$11.30M
YoY Change	23388.84%	26.38%
Total Short-Term Liabilities	$1.113B	$451.8M
YoY Change	146.25%	89.19%
LONG-TERM LIABILITIES
Long-Term Debt	1.265B CNies	$81.91M
YoY Change	1443.85%	5.72%
Other Long-Term Liabilities	$55.32M	$45.31M
YoY Change	22.11%	-5.46%
Total Long-Term Liabilities	$704.9M	$788.4M
YoY Change	-10.59%	153.7%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.113B	$451.8M
Total Long-Term Liabilities	$704.9M	$788.4M
Total Liabilities	$1.817B	$1.240B
YoY Change	46.55%	125.67%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.486B	-$2.320B
YoY Change	50.3%	97.44%
Common Stock	$119.0K	$101.0K
YoY Change	17.82%	29.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.004B	$2.812B
YoY Change
Total Liabilities & Shareholders Equity	$5.821B	$4.067B
YoY Change	43.12%	87.24%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	$66.50M	-$363.7M
YoY Change	-118.28%	116.97%
Depreciation, Depletion And Amortization	$9.632M	$7.750M
YoY Change	24.28%	126.87%
Cash From Operating Activities	$125.1M	-$341.9M
YoY Change	-136.58%	98.83%
INVESTING ACTIVITIES
Capital Expenditures	$42.39M	$21.53M
YoY Change	96.86%	-1.35%
Acquisitions
YoY Change
Other Investing Activities	$1.419B
YoY Change
Cash From Investing Activities	$291.9M	-$1.115B
YoY Change	-126.18%	-746.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00	$2.162B
YoY Change	-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$107.4M	$2.802B
YoY Change	-96.17%	6422.13%
NET CHANGE
Cash From Operating Activities	$125.1M	-$341.9M
Cash From Investing Activities	$291.9M	-$1.115B
Cash From Financing Activities	$107.4M	$2.802B
Net Change In Cash	$520.4M	$1.339B
YoY Change	-61.14%	2708.98%
FREE CASH FLOW
Cash From Operating Activities	$125.1M	-$341.9M
Capital Expenditures	$42.39M	$21.53M
Free Cash Flow	$82.71M	-$363.5M
YoY Change	-122.75%	87.55%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001651308
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	001-37686
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	BEIGENE, LTD.
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1209416
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	c/o Mourant Governance Services (Cayman) Limited
CY2021Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	94 Solaris Avenue, Camana Bay
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Grand Cayman
CY2021Q1	dei	Entity Address Country EntityAddressCountry	KY
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	KY1-1108
CY2021Q1	dei	City Area Code CityAreaCode	345
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	949-4123
CY2021Q1	dei	Security12b Title Security12bTitle	American Depositary Shares, each representing 13 Ordinary Shares, par value $0.0001 per share
CY2021Q1	dei	Trading Symbol TradingSymbol	BGNE
CY2021Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1197609020	shares
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1901819000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1381950000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	305000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	307000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	2910472000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	3268725000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	84010000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	60403000	USD
CY2021Q1	us-gaap	Inventory Net InventoryNet	72974000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	89293000	USD
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	171399000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	160012000	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	5140979000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	4960690000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	8282000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	7748000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	373949000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	357686000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	86946000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	90581000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4813000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5000000	USD
CY2021Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	78215000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	65962000	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	127820000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	113090000	USD
CY2021Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	680025000	USD
CY2020Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	640067000	USD
CY2021Q1	us-gaap	Assets Assets	5821004000	USD
CY2020Q4	us-gaap	Assets Assets	5600757000	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	146923000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	231957000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	312134000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	346144000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	71651000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	USD
CY2021Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	27463000	USD
CY2020Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	20380000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	13993000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	13895000	USD
CY2021Q1	bgne	Research And Development Cost Share Liability Current Portion ResearchAndDevelopmentCostShareLiabilityCurrentPortion	135333000	USD
CY2020Q4	bgne	Research And Development Cost Share Liability Current Portion ResearchAndDevelopmentCostShareLiabilityCurrentPortion	127808000	USD
CY2021Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	405045000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	335015000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1112542000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1075199000	USD
CY2021Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	193017000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	183637000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	78594000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	0	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	26565000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	29417000	USD
CY2021Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	10794000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	10792000	USD
CY2021Q1	bgne	Research And Development Cost Share Liability Noncurrent Portion ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion	340585000	USD
CY2020Q4	bgne	Research And Development Cost Share Liability Noncurrent Portion ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion	375040000	USD
CY2021Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	55320000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	57429000	USD
CY2021Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	704875000	USD
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	656315000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	1817417000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	1731514000	USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	9500000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	9500000000	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1197322617	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1197322617	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1190821941	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1190821941	shares
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	119000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	118000	USD
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	7486518000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	7414932000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3204000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	6942000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3486254000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3552749000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	4003587000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	3869243000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5821004000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5600757000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	605872000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	52059000	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	32685000	USD
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	14149000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	320726000	USD
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	304302000	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	182106000	USD
CY2020Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	107081000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	188000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	283000	USD
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	535705000	USD
CY2020Q1	us-gaap	Costs And Expenses CostsAndExpenses	425815000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	70167000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-373756000	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4179000	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	6690000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4123000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3681000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	61865000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-363385000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4630000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1554000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	66495000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-364939000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1204000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	66495000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-363735000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1188943726	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1005347581	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1257489671	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1005347581	shares
CY2021Q1	bgne	Earnings Per American Depository Share Basic EarningsPerAmericanDepositoryShareBasic	0.73
CY2020Q1	bgne	Earnings Per American Depository Share Basic EarningsPerAmericanDepositoryShareBasic	-4.70
CY2021Q1	bgne	Earnings Per American Depository Share Diluted EarningsPerAmericanDepositoryShareDiluted	0.69
CY2020Q1	bgne	Earnings Per American Depository Share Diluted EarningsPerAmericanDepositoryShareDiluted	-4.70
CY2021Q1	bgne	Weighted Average Number Of American Depository Shares Outstanding Basic WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic	91457210	shares
CY2020Q1	bgne	Weighted Average Number Of American Depository Shares Outstanding Basic WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic	77334429	shares
CY2021Q1	bgne	Weighted Average Number Of American Depository Shares Outstanding Diluted WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted	96729975	shares
CY2020Q1	bgne	Weighted Average Number Of American Depository Shares Outstanding Diluted WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted	77334429	shares
CY2021Q1	us-gaap	Profit Loss ProfitLoss	66495000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-364939000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3762000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-4349000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-497000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	0	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-473000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	5698000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	62757000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-363590000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3236000	USD
CY2021Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-12251000	USD
CY2020Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-206000	USD
CY2021Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	5263000	USD
CY2020Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	3489000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	23656000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1308000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	62757000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-362282000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	66495000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-364939000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9632000	USD
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7750000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	45833000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	38255000	USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3327000	USD
CY2020Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	6964000	USD
CY2021Q1	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	8500000	USD
CY2020Q1	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	43000000	USD
CY2021Q1	bgne	Amortizationof Research And Development Financing Liability AmortizationofResearchAndDevelopmentFinancingLiability	-26930000	USD
CY2020Q1	bgne	Amortizationof Research And Development Financing Liability AmortizationofResearchAndDevelopmentFinancingLiability	-27634000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-16319000	USD
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	222000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	11453000	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	36075000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	6495000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	2710000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-73178000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-21450000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-34010000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	15775000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	7149000	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	6080000	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	150245000	USD
CY2020Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	USD
CY2021Q1	bgne	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	1215000	USD
CY2020Q1	bgne	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	1927000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-910000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-1256000	USD
CY2021Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	10664000	USD
CY2020Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2021Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	71001000	USD
CY2020Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	11298000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	25754000	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	11629000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	107419000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2802168000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-4061000	USD
CY2020Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-6212000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	125095000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-341944000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	42389000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21533000	USD
CY2021Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	764163000	USD
CY2020Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1307179000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	1107000000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	256743000	USD
CY2021Q1	bgne	Payments To Purchase In Process Research And Development PaymentsToPurchaseInProcessResearchAndDevelopment	8500000	USD
CY2020Q1	bgne	Payments To Purchase In Process Research And Development PaymentsToPurchaseInProcessResearchAndDevelopment	43000000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	291948000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1114969000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2162407000	USD
CY2021Q1	bgne	Proceeds From Research And Development Financing Liability ProceedsFromResearchAndDevelopmentFinancingLiability	0	USD
CY2020Q1	bgne	Proceeds From Research And Development Financing Liability ProceedsFromResearchAndDevelopmentFinancingLiability	616834000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	520401000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1339043000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1390005000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	620775000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1910406000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1959818000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1901819000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1957101000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	305000	USD
CY2020Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	282000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	8282000	USD
CY2020Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	2435000	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	478000	USD
CY2020Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	531000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	6927000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	1136000	USD
CY2021Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	30906000	USD
CY2020Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	26412000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3869243000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	25754000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	45833000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3738000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	66495000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4003587000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	978355000	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	11629000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	38255000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1349000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-364939000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2827056000	USD
CY2021Q1	bgne	Number Of Molecules NumberOfMolecules	10	molecule
CY2021Q1	bgne	Number Of Persons NumberOfPersons	1600	people
CY2021Q1	bgne	Product Candidate ProductCandidate	3	product
CY2021Q1	bgne	Products In Commercial Or Clinical Development ProductsInCommercialORClinicalDevelopment	45	product
CY2021Q1	dei	Entity Number Of Employees EntityNumberOfEmployees	6000	employee
CY2021Q1	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	16	country
CY2021Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Areas where management uses subjective judgment include, but are not limited to, estimating the useful lives of long-lived assets, estimating variable consideration in product sales and collaboration revenue arrangements, identifying separate accounting units and determining the standalone selling price of each performance obligation in the Company’s revenue arrangements, estimating the fair value of net assets acquired in business combinations, assessing the impairment of long-lived assets, valuation and recognition of share-based compensation expenses, realizability of deferred tax assets, estimating uncertain tax positions, valuation of inventory, estimating the allowance for credit losses, determining defined benefit pension plan obligations, measurement of right-of-use assets and lease liabilities and the fair value of financial instruments. Management bases the estimates on historical experience, known trends and various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from these estimates.</span></div>
CY2021Q1	bgne	Reimbursement Expense ReimbursementExpense	6248000	USD
CY2020Q1	bgne	Reimbursement Expense ReimbursementExpense	0	USD
CY2021Q1	us-gaap	Restricted Cash RestrictedCash	8587000	USD
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	8055000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	2910074000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	398000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	2910472000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	3267875000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	850000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	3268725000	USD
CY2021Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	18702000	USD
CY2020Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	9705000	USD
CY2021Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	26894000	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	19330000	USD
CY2021Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	9504000	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1378000	USD
CY2021Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	36576000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	68585000	USD
CY2021Q1	us-gaap	Inventory Net InventoryNet	72974000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	89293000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	387004000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	345261000	USD
CY2021Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	83829000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	73354000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	373949000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	357686000	USD
CY2021Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	70774000	USD
CY2020Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	85779000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	9444000	USD
CY2020Q1	us-gaap	Depreciation Depreciation	7467000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4630000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8316000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3503000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4813000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8316000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3316000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5000000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	188000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	283000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	563000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	750000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	750000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	750000	USD
CY2021Q1	bgne	Finite Lived Intangible Asset Expected Amortization After Year Three FiniteLivedIntangibleAssetExpectedAmortizationAfterYearThree	2000000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1554000	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	7727000	USD
CY2021Q1	bgne	Unrecognized Tax Benefits Increase Resulting From Tax Credit And Incentives UnrecognizedTaxBenefitsIncreaseResultingFromTaxCreditAndIncentives	604000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	112000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	48000	USD
CY2020Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2022000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	USD
CY2021Q1	bgne	Accounts Receivable Allowance For Credit Loss Exchange Rate Changes AccountsReceivableAllowanceForCreditLossExchangeRateChanges	1000	USD
CY2020Q1	bgne	Accounts Receivable Allowance For Credit Loss Exchange Rate Changes AccountsReceivableAllowanceForCreditLossExchangeRateChanges	0	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	161000	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2022000	USD
CY2021Q1	bgne	Prepaid Research And Development Costs PrepaidResearchAndDevelopmentCosts	69382000	USD
CY2020Q4	bgne	Prepaid Research And Development Costs PrepaidResearchAndDevelopmentCosts	71341000	USD
CY2021Q1	us-gaap	Prepaid Taxes PrepaidTaxes	30299000	USD
CY2020Q4	us-gaap	Prepaid Taxes PrepaidTaxes	30392000	USD
CY2021Q1	bgne	Payroll Tax Receivable Current PayrollTaxReceivableCurrent	6120000	USD
CY2020Q4	bgne	Payroll Tax Receivable Current PayrollTaxReceivableCurrent	3580000	USD
CY2021Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	2974000	USD
CY2020Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	4464000	USD
CY2021Q1	us-gaap	Interest Receivable Current InterestReceivableCurrent	6284000	USD
CY2020Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	6619000	USD
CY2021Q1	us-gaap	Prepaid Insurance PrepaidInsurance	10459000	USD
CY2020Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1347000	USD
CY2021Q1	bgne	Prepaid Manufacturing Costs PrepaidManufacturingCosts	23238000	USD
CY2020Q4	bgne	Prepaid Manufacturing Costs PrepaidManufacturingCosts	25996000	USD
CY2021Q1	us-gaap	Prepaid Advertising PrepaidAdvertising	4004000	USD
CY2020Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	0	USD
CY2021Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	4540000	USD
CY2020Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	4607000	USD
CY2021Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	14099000	USD
CY2020Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	11666000	USD
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	171399000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	160012000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	109000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	109000	USD
CY2021Q1	bgne	Prepayment Of Long Term Asset PrepaymentOfLongTermAsset	22584000	USD
CY2020Q4	bgne	Prepayment Of Long Term Asset PrepaymentOfLongTermAsset	16984000	USD
CY2021Q1	bgne	Prepaid Construction Cost PrepaidConstructionCost	25652000	USD
CY2020Q4	bgne	Prepaid Construction Cost PrepaidConstructionCost	29778000	USD
CY2021Q1	us-gaap	Value Added Tax Receivable Noncurrent ValueAddedTaxReceivableNoncurrent	16781000	USD
CY2020Q4	us-gaap	Value Added Tax Receivable Noncurrent ValueAddedTaxReceivableNoncurrent	10913000	USD
CY2021Q1	bgne	Rental Deposits And Other RentalDepositsAndOther	6983000	USD
CY2020Q4	bgne	Rental Deposits And Other RentalDepositsAndOther	5962000	USD
CY2021Q1	us-gaap	Long Term Investments LongTermInvestments	55711000	USD
CY2020Q4	us-gaap	Long Term Investments LongTermInvestments	49344000	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	127820000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	113090000	USD
CY2021Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	49056000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	106765000	USD
CY2021Q1	bgne	Accrued Liabilities External Research And Development AccruedLiabilitiesExternalResearchAndDevelopment	126228000	USD
CY2020Q4	bgne	Accrued Liabilities External Research And Development AccruedLiabilitiesExternalResearchAndDevelopment	143302000	USD
CY2021Q1	bgne	Accrued Expenses Commercial Activities AccruedExpensesCommercialActivities	63219000	USD
CY2020Q4	bgne	Accrued Expenses Commercial Activities AccruedExpensesCommercialActivities	66131000	USD
CY2021Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	19762000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	14373000	USD
CY2021Q1	bgne	Accrued Sales Rebates And Returns Current AccruedSalesRebatesAndReturnsCurrent	45665000	USD
CY2020Q4	bgne	Accrued Sales Rebates And Returns Current AccruedSalesRebatesAndReturnsCurrent	11874000	USD
CY2021Q1	bgne	Accrued Professional Fees And Other Current AccruedProfessionalFeesAndOtherCurrent	8204000	USD
CY2020Q4	bgne	Accrued Professional Fees And Other Current AccruedProfessionalFeesAndOtherCurrent	3699000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	312134000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	346144000	USD
CY2021Q1	bgne	Government Grants Or Incentives Received And Deferred Noncurrent GovernmentGrantsOrIncentivesReceivedAndDeferredNoncurrent	47528000	USD
CY2020Q4	bgne	Government Grants Or Incentives Received And Deferred Noncurrent GovernmentGrantsOrIncentivesReceivedAndDeferredNoncurrent	49139000	USD
CY2021Q1	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	7616000	USD
CY2020Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	8113000	USD
CY2021Q1	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	176000	USD
CY2020Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	177000	USD
CY2021Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	55320000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	57429000	USD
CY2021Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	405045000	USD
CY2021Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	2653769000	CNY
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	335015000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2185928000	CNY
CY2021Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	193017000	USD
CY2021Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1264611000	CNY
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	183637000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1198206000	CNY
CY2021Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	6950000	USD
CY2020Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	4291000	USD
CY2021Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2021Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	104000	USD
CY2020Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	66000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	66495000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-364939000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1204000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	66495000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-363735000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1188943726	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1005347581	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	68545945	shares
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1257489671	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1005347581	shares
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	45833000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	38255000	USD
CY2021Q1	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	141159000	USD
CY2021Q1	bgne	Restricted Net Assets Minimum Required Statutory Reserve Of Annual After Tax Profit Percentage RestrictedNetAssetsMinimumRequiredStatutoryReserveOfAnnualAfterTaxProfitPercentage	0.10
CY2021Q1	bgne	Restricted Net Assets Required Statutory Reserve As Percentage Of Registered Capital RestrictedNetAssetsRequiredStatutoryReserveAsPercentageOfRegisteredCapital	0.50
CY2021Q1	bgne	Restricted Net Assets Minimum Required Statutory Reserve Of Annual After Tax Profit Percentage RestrictedNetAssetsMinimumRequiredStatutoryReserveOfAnnualAfterTaxProfitPercentage	0.10
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	605872000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	52059000	USD

Files In Submission

Name	View Source	Status
0001651308-21-000086-index-headers.html	Edgar Link	pending
0001651308-21-000086-index.html	Edgar Link	pending
0001651308-21-000086.txt	Edgar Link	pending
0001651308-21-000086-xbrl.zip	Edgar Link	pending
bgne-20210331.htm	Edgar Link	pending
bgne-20210331.xsd	Edgar Link	pending
bgne-20210331_cal.xml	Edgar Link	unprocessable
bgne-20210331_def.xml	Edgar Link	unprocessable
bgne-20210331_htm.xml	Edgar Link	completed
bgne-20210331_lab.xml	Edgar Link	unprocessable
bgne-20210331_pre.xml	Edgar Link	unprocessable
exhibit101-collaborationan.htm	Edgar Link	pending
exhibit311-2021q1.htm	Edgar Link	pending
exhibit312-2021q1.htm	Edgar Link	pending
exhibit321-2021q1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ONC
BeiGene, Ltd. Stock $onc

2021 Q1 Form 10-Q Financial Statement

#000165130821000086 Filed on May 06, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONC BeiGene, Ltd. Stock $onc

2021 Q1 Form 10-Q Financial Statement

#000165130821000086 Filed on May 06, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONC
BeiGene, Ltd. Stock $onc